| http://www.w3.org/ns/prov#value | - These statements relate to future events or to VIA's future financial performance and involve known and unknown risks, uncertainties and other factors that may cause VIA's ac...New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients...of the Private Securities Litigation Reform Act of 1995, including statements relating to the potential market f
|
